Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants

Infections in infants, after childbirth, remain a leading cause of neonatal morbidity and mortality, globally. A soaring percentage of these infections arise from bacterial colonization of the umbilicus. Current therapy for omphalitis includes the topical application of chlorhexidine on the umbilicu...

Full description

Saved in:
Bibliographic Details
Main Authors: Ibilola Mary Cardoso-Daodu, Margaret Okonawan Ilomuanya
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:http://dx.doi.org/10.1155/adpp/6828052
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206924174426112
author Ibilola Mary Cardoso-Daodu
Margaret Okonawan Ilomuanya
author_facet Ibilola Mary Cardoso-Daodu
Margaret Okonawan Ilomuanya
author_sort Ibilola Mary Cardoso-Daodu
collection DOAJ
description Infections in infants, after childbirth, remain a leading cause of neonatal morbidity and mortality, globally. A soaring percentage of these infections arise from bacterial colonization of the umbilicus. Current therapy for omphalitis includes the topical application of chlorhexidine on the umbilicus. Bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, which are the key causative organisms of omphalitis, are resistant to chlorhexidine. In this study, curcumin-loaded liposomes were prepared using the “thin film hydration” method. Liposomes were characterized by particle size analysis, light microscopy, encapsulation efficiency, and flux. Stable organogels were formed via a high-speed homogenization method and stabilized by an emulsifier mix. They were evaluated for stability over a period by observing for phase separation. Four gels F1 (curcumin-loaded liposomes in chlorhexidine organogel), F2 (curcumin-loaded liposomes in organogel), F3 (chlorhexidine in organogel), and control (plain organogel) were prepared. Physicochemical properties of all gels were evaluated such as organoleptic tests, gel-to-sol transition, rheological studies, pH, skin irritancy, spreadability, accelerated stability, and antibacterial activity studies. Liposomes were spherical with an average size of 7 μm and an encapsulation efficiency of 97%. The in vitro release profile best fits the Higuchi mathematical model implying that curcumin release was by diffusion and dissolution mechanism. In vitro release was also higher at pH 5.5. F1 had the highest spreadability of 63 mm2g−1 and the lowest viscosity of 184,400 MPas at a shear rate of 10 rotations per minute with a pH of 6.5. Formulation F1 also displayed the highest antibacterial activity against all three bacteria. It can be concluded that the synergistic interaction between curcumin and chlorhexidine may be responsible for the significant antibacterial potency exhibited in formulation F1. Curcumin-loaded liposomes in chlorhexidine organogel (F1) can serve as a prototype for the development of an antibacterial topical formulation having intrinsic activity and enhanced potency to combat omphalitis.
format Article
id doaj-art-1269cc37842a41c985a5f8e784fbd0f9
institution Kabale University
issn 2633-4690
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological and Pharmaceutical Sciences
spelling doaj-art-1269cc37842a41c985a5f8e784fbd0f92025-02-07T00:47:30ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902025-01-01202510.1155/adpp/6828052Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in InfantsIbilola Mary Cardoso-Daodu0Margaret Okonawan Ilomuanya1Department of Pharmaceutics and Pharmaceutical TechnologyDepartment of Pharmaceutics and Pharmaceutical TechnologyInfections in infants, after childbirth, remain a leading cause of neonatal morbidity and mortality, globally. A soaring percentage of these infections arise from bacterial colonization of the umbilicus. Current therapy for omphalitis includes the topical application of chlorhexidine on the umbilicus. Bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, which are the key causative organisms of omphalitis, are resistant to chlorhexidine. In this study, curcumin-loaded liposomes were prepared using the “thin film hydration” method. Liposomes were characterized by particle size analysis, light microscopy, encapsulation efficiency, and flux. Stable organogels were formed via a high-speed homogenization method and stabilized by an emulsifier mix. They were evaluated for stability over a period by observing for phase separation. Four gels F1 (curcumin-loaded liposomes in chlorhexidine organogel), F2 (curcumin-loaded liposomes in organogel), F3 (chlorhexidine in organogel), and control (plain organogel) were prepared. Physicochemical properties of all gels were evaluated such as organoleptic tests, gel-to-sol transition, rheological studies, pH, skin irritancy, spreadability, accelerated stability, and antibacterial activity studies. Liposomes were spherical with an average size of 7 μm and an encapsulation efficiency of 97%. The in vitro release profile best fits the Higuchi mathematical model implying that curcumin release was by diffusion and dissolution mechanism. In vitro release was also higher at pH 5.5. F1 had the highest spreadability of 63 mm2g−1 and the lowest viscosity of 184,400 MPas at a shear rate of 10 rotations per minute with a pH of 6.5. Formulation F1 also displayed the highest antibacterial activity against all three bacteria. It can be concluded that the synergistic interaction between curcumin and chlorhexidine may be responsible for the significant antibacterial potency exhibited in formulation F1. Curcumin-loaded liposomes in chlorhexidine organogel (F1) can serve as a prototype for the development of an antibacterial topical formulation having intrinsic activity and enhanced potency to combat omphalitis.http://dx.doi.org/10.1155/adpp/6828052
spellingShingle Ibilola Mary Cardoso-Daodu
Margaret Okonawan Ilomuanya
Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
Advances in Pharmacological and Pharmaceutical Sciences
title Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
title_full Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
title_fullStr Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
title_full_unstemmed Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
title_short Development of Curcumin Encapsulated Liposomes in Chlorhexidine-Loaded Organogel Using Ternary Phase Systems for Treatment of Omphalitis in Infants
title_sort development of curcumin encapsulated liposomes in chlorhexidine loaded organogel using ternary phase systems for treatment of omphalitis in infants
url http://dx.doi.org/10.1155/adpp/6828052
work_keys_str_mv AT ibilolamarycardosodaodu developmentofcurcuminencapsulatedliposomesinchlorhexidineloadedorganogelusingternaryphasesystemsfortreatmentofomphalitisininfants
AT margaretokonawanilomuanya developmentofcurcuminencapsulatedliposomesinchlorhexidineloadedorganogelusingternaryphasesystemsfortreatmentofomphalitisininfants